Glucose-regulated protein 78 regulates multiple malignant phenotypes in head and neck cancer and may serve as a molecular target of therapeutic intervention

Ching Chi Chiu, Chien Yu Lin, Li Yu Lee, Yin Ju Chen, Ting Fang Kuo, Joseph Tung Chieh Chang, Chun Ta Liao, Hung Ming Wang, Tzu Chen Yen, Chia Rui Shen, Shuen Kuei Liao, Ann Joy Cheng

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

Glucose-regulated protein 78 (Grp78) is an endoplasmic reticulum chaperone protein and is overexpressed in various cancers. However, it is unclear how significance of this molecule play an active role contributing to the oncogenic effect of head and neck cancer (HNC). To investigate the potential function of Grp78, six HNC cell lines were used. We found that Grp78 is highly expressed in all six cell lines and many of the proteins were localized in the periphery regions, implying other function of this molecule aside from endoplasmic reticulum stress response. Knockdown of Grp78 by small interfering RNA significantly reduced cell growth and colony formation to 53% to 12% compared with that of controls in all six HNC cell lines. Using in vitro wound healing and Matrigel invasion assays, we found that cell migration and invasive ability were also inhibited to 23% to 2% in all these cell lines tested. In vivo xenograft studies showed that administration of Grp78-small interfering RNA plasmid into HNC xenografts significantly inhibited both tumor growth in situ (>60% inhibition at day 34) and liver metastasis (>90% inhibition at day 20). Our study showed that Grp78 actively regulates multiple malignant phenotypes, including cell growth, migration, and invasion. Because knockdown Grp78 expression succeeds in the reduction of tumor growth and metastatic potential, this molecule may serve as a molecular target of therapeutic intervention for HNC.

Original languageEnglish
Pages (from-to)2788-2797
Number of pages10
JournalMolecular Cancer Therapeutics
Volume7
Issue number9
DOIs
Publication statusPublished - 2008
Externally publishedYes

Fingerprint

Head and Neck Neoplasms
Phenotype
Cell Line
Growth
Heterografts
Small Interfering RNA
Therapeutics
Cell Migration Assays
Neoplasms
Endoplasmic Reticulum Stress
glucose-regulated proteins
Endoplasmic Reticulum
Wound Healing
Cell Movement
Proteins
Plasmids
Neoplasm Metastasis
Liver

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Glucose-regulated protein 78 regulates multiple malignant phenotypes in head and neck cancer and may serve as a molecular target of therapeutic intervention. / Chiu, Ching Chi; Lin, Chien Yu; Lee, Li Yu; Chen, Yin Ju; Kuo, Ting Fang; Chang, Joseph Tung Chieh; Liao, Chun Ta; Wang, Hung Ming; Yen, Tzu Chen; Shen, Chia Rui; Liao, Shuen Kuei; Cheng, Ann Joy.

In: Molecular Cancer Therapeutics, Vol. 7, No. 9, 2008, p. 2788-2797.

Research output: Contribution to journalArticle

Chiu, Ching Chi ; Lin, Chien Yu ; Lee, Li Yu ; Chen, Yin Ju ; Kuo, Ting Fang ; Chang, Joseph Tung Chieh ; Liao, Chun Ta ; Wang, Hung Ming ; Yen, Tzu Chen ; Shen, Chia Rui ; Liao, Shuen Kuei ; Cheng, Ann Joy. / Glucose-regulated protein 78 regulates multiple malignant phenotypes in head and neck cancer and may serve as a molecular target of therapeutic intervention. In: Molecular Cancer Therapeutics. 2008 ; Vol. 7, No. 9. pp. 2788-2797.
@article{b0c77deb67a9441ca2c48ba02d77f677,
title = "Glucose-regulated protein 78 regulates multiple malignant phenotypes in head and neck cancer and may serve as a molecular target of therapeutic intervention",
abstract = "Glucose-regulated protein 78 (Grp78) is an endoplasmic reticulum chaperone protein and is overexpressed in various cancers. However, it is unclear how significance of this molecule play an active role contributing to the oncogenic effect of head and neck cancer (HNC). To investigate the potential function of Grp78, six HNC cell lines were used. We found that Grp78 is highly expressed in all six cell lines and many of the proteins were localized in the periphery regions, implying other function of this molecule aside from endoplasmic reticulum stress response. Knockdown of Grp78 by small interfering RNA significantly reduced cell growth and colony formation to 53{\%} to 12{\%} compared with that of controls in all six HNC cell lines. Using in vitro wound healing and Matrigel invasion assays, we found that cell migration and invasive ability were also inhibited to 23{\%} to 2{\%} in all these cell lines tested. In vivo xenograft studies showed that administration of Grp78-small interfering RNA plasmid into HNC xenografts significantly inhibited both tumor growth in situ (>60{\%} inhibition at day 34) and liver metastasis (>90{\%} inhibition at day 20). Our study showed that Grp78 actively regulates multiple malignant phenotypes, including cell growth, migration, and invasion. Because knockdown Grp78 expression succeeds in the reduction of tumor growth and metastatic potential, this molecule may serve as a molecular target of therapeutic intervention for HNC.",
author = "Chiu, {Ching Chi} and Lin, {Chien Yu} and Lee, {Li Yu} and Chen, {Yin Ju} and Kuo, {Ting Fang} and Chang, {Joseph Tung Chieh} and Liao, {Chun Ta} and Wang, {Hung Ming} and Yen, {Tzu Chen} and Shen, {Chia Rui} and Liao, {Shuen Kuei} and Cheng, {Ann Joy}",
year = "2008",
doi = "10.1158/1535-7163.MCT-08-0172",
language = "English",
volume = "7",
pages = "2788--2797",
journal = "Molecular Cancer Therapeutics",
issn = "1535-7163",
publisher = "American Association for Cancer Research Inc.",
number = "9",

}

TY - JOUR

T1 - Glucose-regulated protein 78 regulates multiple malignant phenotypes in head and neck cancer and may serve as a molecular target of therapeutic intervention

AU - Chiu, Ching Chi

AU - Lin, Chien Yu

AU - Lee, Li Yu

AU - Chen, Yin Ju

AU - Kuo, Ting Fang

AU - Chang, Joseph Tung Chieh

AU - Liao, Chun Ta

AU - Wang, Hung Ming

AU - Yen, Tzu Chen

AU - Shen, Chia Rui

AU - Liao, Shuen Kuei

AU - Cheng, Ann Joy

PY - 2008

Y1 - 2008

N2 - Glucose-regulated protein 78 (Grp78) is an endoplasmic reticulum chaperone protein and is overexpressed in various cancers. However, it is unclear how significance of this molecule play an active role contributing to the oncogenic effect of head and neck cancer (HNC). To investigate the potential function of Grp78, six HNC cell lines were used. We found that Grp78 is highly expressed in all six cell lines and many of the proteins were localized in the periphery regions, implying other function of this molecule aside from endoplasmic reticulum stress response. Knockdown of Grp78 by small interfering RNA significantly reduced cell growth and colony formation to 53% to 12% compared with that of controls in all six HNC cell lines. Using in vitro wound healing and Matrigel invasion assays, we found that cell migration and invasive ability were also inhibited to 23% to 2% in all these cell lines tested. In vivo xenograft studies showed that administration of Grp78-small interfering RNA plasmid into HNC xenografts significantly inhibited both tumor growth in situ (>60% inhibition at day 34) and liver metastasis (>90% inhibition at day 20). Our study showed that Grp78 actively regulates multiple malignant phenotypes, including cell growth, migration, and invasion. Because knockdown Grp78 expression succeeds in the reduction of tumor growth and metastatic potential, this molecule may serve as a molecular target of therapeutic intervention for HNC.

AB - Glucose-regulated protein 78 (Grp78) is an endoplasmic reticulum chaperone protein and is overexpressed in various cancers. However, it is unclear how significance of this molecule play an active role contributing to the oncogenic effect of head and neck cancer (HNC). To investigate the potential function of Grp78, six HNC cell lines were used. We found that Grp78 is highly expressed in all six cell lines and many of the proteins were localized in the periphery regions, implying other function of this molecule aside from endoplasmic reticulum stress response. Knockdown of Grp78 by small interfering RNA significantly reduced cell growth and colony formation to 53% to 12% compared with that of controls in all six HNC cell lines. Using in vitro wound healing and Matrigel invasion assays, we found that cell migration and invasive ability were also inhibited to 23% to 2% in all these cell lines tested. In vivo xenograft studies showed that administration of Grp78-small interfering RNA plasmid into HNC xenografts significantly inhibited both tumor growth in situ (>60% inhibition at day 34) and liver metastasis (>90% inhibition at day 20). Our study showed that Grp78 actively regulates multiple malignant phenotypes, including cell growth, migration, and invasion. Because knockdown Grp78 expression succeeds in the reduction of tumor growth and metastatic potential, this molecule may serve as a molecular target of therapeutic intervention for HNC.

UR - http://www.scopus.com/inward/record.url?scp=54049114742&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=54049114742&partnerID=8YFLogxK

U2 - 10.1158/1535-7163.MCT-08-0172

DO - 10.1158/1535-7163.MCT-08-0172

M3 - Article

C2 - 18790759

AN - SCOPUS:54049114742

VL - 7

SP - 2788

EP - 2797

JO - Molecular Cancer Therapeutics

JF - Molecular Cancer Therapeutics

SN - 1535-7163

IS - 9

ER -